Open access
Open access
Powered by Google Translator Translator

Chest Medicine

Brief Review | Extubation in neurocritical care patients: lesson learned.

25 Nov, 2022 | 12:31h | UTC

Extubation in neurocritical care patients: lesson learned – Intensive Care Medicine

 

Commentary on Twitter

 

Cohort Study | Development of interstitial lung disease among patients with atrial fibrillation receiving oral anticoagulants.

25 Nov, 2022 | 12:23h | UTC

Development of Interstitial Lung Disease Among Patients With Atrial Fibrillation Receiving Oral Anticoagulants in Taiwan – JAMA Network Open

Commentaries:

Interstitial Lung Disease With Non–Vitamin K Oral Anticoagulants—A Clinical Concern? – JAMA Network Open

Slight Risk of Interstitial Lung Disease Seen With Certain DOACs – TCTMD

 

RCT | Anticoagulation for 3 months reduces recurrence rates vs. treatment for 6 weeks in patients with isolated distal DVT.

24 Nov, 2022 | 13:34h | UTC

Rivaroxaban treatment for six weeks versus three months in patients with symptomatic isolated distal deep vein thrombosis: randomised controlled trial – The BMJ

News Release: Extending anti-clotting treatment after distal DVT reduces further clot risk – BMJ Newsroom

 

Review | Care of the seriously ill patient with SARS-CoV-2.

24 Nov, 2022 | 13:26h | UTC

Care of the Seriously Ill Patient with SARS-CoV-2 – Medical Clinics of North America

 

RCT | Low-dose morphine did not significantly reduce the intensity of chronic breathlessness in patients with COPD.

23 Nov, 2022 | 14:09h | UTC

Effect of Regular, Low-Dose, Extended-release Morphine on Chronic Breathlessness in Chronic Obstructive Pulmonary Disease: The BEAMS Randomized Clinical Trial – JAMA (free for a limited period)

Editorial: Dyspnea—When a Sensation Becomes a Symptom – JAMA (free for a limited period)

See also: Visual Abstract

Commentary: Breathlessness in Patients with COPD isn’t Reduced with Daily Morphine – HCP Live

 

Right heart failure in the ED: approach to diagnosis and management.

23 Nov, 2022 | 13:54h | UTC

Right Heart Failure in the ED: Approach to Diagnosis and Management – emDocs

 

RCT | Discontinuation vs. continuation of hypertonic saline or dornase alfa in modulator treated people with cystic fibrosis.

23 Nov, 2022 | 13:36h | UTC

Discontinuation versus continuation of hypertonic saline or dornase alfa in modulator treated people with cystic fibrosis (SIMPLIFY): results from two parallel, multicentre, open-label, randomised, controlled, non-inferiority trials – The Lancet Respiratory Medicine (free registration required)

 

Commentary on Twitter

 

M-A | Burden of respiratory syncytial virus infection in older and high-risk adults in developed countries.

22 Nov, 2022 | 13:05h | UTC

Burden of respiratory syncytial virus infection in older and high-risk adults: a systematic review and meta-analysis of the evidence from developed countries – European Respiratory Review 

 

RCT | NIV is superior to high-flow nasal cannula to prevent reintubation in patients at high risk for extubation failure.

21 Nov, 2022 | 14:41h | UTC

Effect of postextubation noninvasive ventilation with active humidification vs high-flow nasal cannula on reintubation in patients at very high risk for extubation failure: a randomized trial – Intensive Care Medicine (free for a limited period) 

 

Commentary on Twitter 

 

 

International guidelines and consensus on the use of lung ultrasound.

21 Nov, 2022 | 14:30h | UTC

New International Guidelines and Consensus on the Use of Lung Ultrasound – Journal of Ultrasound Medicine 

 

Portopulmonary hypertension: current developments and future perspectives.

21 Nov, 2022 | 14:20h | UTC

Portopulmonary hypertension: Current developments and future perspectives – Liver Research 

Related: Pulmonary complications in liver disease – Intensive Care Medicine (free) 

Related Reviews:  

Hepatopulmonary syndrome and portopulmonary hypertension: recent knowledge in pathogenesis and overview of clinical assessment – Liver International  

Pulmonary complications of hepatic diseases – World Journal of Gastroenterology  

Pulmonary Vascular Complications of Liver Disease – American Journal of Respiratory and Critical Care Medicine 

 

Review | Complications associated with venovenous extracorporeal membrane oxygenation—what can go wrong?

21 Nov, 2022 | 14:12h | UTC

Complications Associated With Venovenous Extracorporeal Membrane Oxygenation—What Can Go Wrong? – Critical Care Medicine 

 

RCT | Influenza vaccine to reduce adverse vascular events in patients with heart failure.

18 Nov, 2022 | 13:26h | UTC

Influenza vaccine to reduce adverse vascular events in patients with heart failure: a multinational randomised, double-blind, placebo-controlled trial – The Lancet Global Health

Commentary: 

Flu vaccines cut pneumonia, cardiovascular issues in heart failure patients – CIDRAP

Flu Shot Could Be Lifesaver for Folks With Heart Failure – HealthDay

 

M-A | Pharmacological interventions on smoking cessation.

18 Nov, 2022 | 13:12h | UTC

Pharmacological interventions on smoking cessation: A systematic review and network meta-analysis – Frontiers in Pharmacology

 

M-A | High-flow nasal cannula vs. non-invasive ventilation for acute hypercapnic respiratory failure in adults.

17 Nov, 2022 | 12:25h | UTC

High-flow nasal cannula versus non-invasive ventilation for acute hypercapnic respiratory failure in adults: a systematic review and meta-analysis of randomized trials – Critical Care

 

Phase 2b RCT | Rituximab vs. IV cyclophosphamide in patients with connective tissue disease-associated interstitial lung disease.

17 Nov, 2022 | 12:24h | UTC

Rituximab versus intravenous cyclophosphamide in patients with connective tissue disease-associated interstitial lung disease in the UK (RECITAL): a double-blind, double-dummy, randomised, controlled, phase 2b trial – The Lancet Respiratory Medicine

Commentaries:

RECITAL: Rituximab represents alternative to cyclophosphamide for CTD-ILD – medwire News

CTD-ILD: Rituximab ‘a Reasonable Alternative to Cyclophosphamide’ – Medscape (free registration required)

 

Commentary on Twitter

https://twitter.com/LancetRespirMed/status/1592057243075112960

 

RCT | Extending the duration of prequit treatment with varenicline did not increase smoking abstinence rates.

17 Nov, 2022 | 12:22h | UTC

Effect of Extending the Duration of Prequit Treatment With Varenicline on Smoking Abstinence: A Randomized Clinical Trial – JAMA Network Open

 

Commentary on Twitter

https://twitter.com/JAMANetworkOpen/status/1591128623947591680

 

USPSTF Statement | There is insufficient evidence to recommend routine screening for obstructive sleep apnea.

16 Nov, 2022 | 13:46h | UTC

Screening for Obstructive Sleep Apnea in Adults: US Preventive Services Task Force Recommendation Statement – JAMA

Evidence Report: Screening for Obstructive Sleep Apnea in Adults: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force – JAMA

Editorial: USPSTF Updates Recommendation for Obstructive Sleep Apnea Screening in Adults – JAMA Otolaryngology—Head & Neck Surgery 

JAMA Patient Page: Screening for Obstructive Sleep Apnea

Author Interview: USPSTF Recommendation: Screening for Obstructive Sleep Apnea in Adults

Commentary: USPSTF: Evidence Inadequate for Recommending OSA Screening – HealthDay

 

SR | Immunostimulants vs. placebo for preventing exacerbations in adults with chronic bronchitis or COPD.

16 Nov, 2022 | 13:34h | UTC

Immunostimulants versus placebo for preventing exacerbations in adults with chronic bronchitis or chronic obstructive pulmonary disease – Cochrane Library

Summary: Is taking an immunostimulant on top of standard medications beneficial for people with chronic obstructive pulmonary disease, chronic bronchitis, or both? – Cochrane Library

 

RCT | Early routine use of ECMO fails to improve outcomes in patients with cardiogenic shock.

11 Nov, 2022 | 14:01h | UTC

Extracorporeal Membrane Oxygenation in the Therapy of Cardiogenic Shock: Results of the ECMO-CS Randomized Clinical Trial – Circulation

Commentaries:

Early use of ECMO devices to support adults with cardiogenic shock did not improve clinical outcomes – News Medical/American Heart Association

Early ECMO No Better Than Watch-and-Wait Approach in Cardiogenic Shock – TCTMD

Immediate Use of ECMO Did Not Improve Outcomes in Patients with Cardiogenic Shock – HCP Live

 

Commentary on Twitter

 

SR | Biomarkers as point‐of‐care tests to guide use of antibiotics in people with acute respiratory infections in primary care.

11 Nov, 2022 | 13:47h | UTC

Biomarkers as point‐of‐care tests to guide prescription of antibiotics in people with acute respiratory infections in primary care – Cochrane Library

 

SR | The availability, cost, and affordability of essential medicines for asthma and COPD in low- and middle-income countries.

11 Nov, 2022 | 13:04h | UTC

The availability, cost, and affordability of essential medicines for asthma and COPD in low-income and middle-income countries: a systematic review – The Lancet Global Health

Invited Commentary: Access to essential respiratory medications remains elusive in LMICs – The Lancet Global Health

 

RCT | Transbronchial needle aspiration combined with cryobiopsy in the diagnosis of mediastinal diseases.

10 Nov, 2022 | 13:54h | UTC

Transbronchial needle aspiration combined with cryobiopsy in the diagnosis of mediastinal diseases: a multicentre, open-label, randomised trial – The Lancet Respiratory Medicine (link to abstract – $ for full-text)

 

Commentary on Twitter

 

Special Issue | Lung transplantation.

10 Nov, 2022 | 13:30h | UTC

Homepage

Indications for Lung Transplantation and Patient Selection

Recipient Management before Lung Transplantation

Allocation of Donor Lungs in Korea

Donor Selection, Management, and Procurement for Lung Transplantation

Donation after Circulatory Death in Lung Transplantation

Ex Vivo Lung Perfusion in Lung Transplantatio

A Review of Anesthesia for Lung Transplantation

Technical Aspects of Lung Transplantation: General Considerations

Technical Aspects of Lung Transplantation: Adverse Events and Circumstances

Technical Aspects of Lung Transplantation: Pediatric and Lobar Transplantation

Technical Aspects of Combined Heart-Lung Transplantation

Critical Care Management Following Lung Transplantation

Surgical Complications Affecting the Early and Late Survival Rates after Lung Transplantation

Medical Complications of Lung Transplantation

Lung Transplantation for Patients with COVID-19 Acute Respiratory Distress Syndrome

 

Review | Direct oral anticoagulants for the prevention and acute treatment of cancer-associated thrombosis.

9 Nov, 2022 | 12:13h | UTC

Direct Oral Anticoagulants for the Prevention and Acute Treatment of Cancer-Associated Thrombosis – Vascular Health and Risk Management

 

Stay Updated in Your Specialty

Telegram Channels
Free

WhatsApp alerts 10-day free trial

No spam, just news.